O-021 Phase 3, Randomized, Double-Blind, Dummy-Controlled, Trial of Radiofrequency Ablation (Rfa) + Lyso-Thermosensitive Liposomal Doxorubicin (Ltld, Thermodox®) for Hepatocellular Carcinoma (HCC) Lesions 3-7Cm

Authors:

W. Y. Tak, S.-M. Lin, Y. Wang, J. Zheng, F. Izzo, S. Y. Park, M. H. Chen, S. N. Wong, R. Xu, C.-Y. Peng, Y.-Y. Chiou, G.-T. Huang, J. Y. Lee, M. Sherman, B. J. J. Abdullah, J. S. Lee, J.-H. Wang, N. Borys, R. T. P. Poon, R. Lencioni